|
1）National Kidney Foundation. K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2000; 35: S1–S140
|
|
|
|
2）Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD. Nephrol Dial Transplant. 2009; 24: 1232-7
|
|
|
|
|
|
3）Raphael KL, Wei G, Baird BC, et al. Higher serum bicarbonate levels with- in the normal range are associated with better survival and renal outcomes in African-Americans. Kidney Int. 2011; 79: 356-62
|
|
|
|
|
4）Dobre M, Yang W, Chen J, et al. Association of plasma bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis. 2013; 62: 670-8
|
|
|
|
|
|
5）Navaneethan SD, Schold JD, Arrigain S, et al. Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease. Clin J Am Soc Nephrol. 2011; 6: 2395-402
|
|
|
|
|
|
6）Kanda E, Ai M, Yoshida M, et al. High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients. BMC Nephrol. 2013; 14: 4
|
|
|
|
|
|
7）Susantitaphong P, Sewaralthahab K, Balk EM, et al. Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review. Am J Nephrol. 2012; 35: 540-7
|
|
|
|
|
|
8）De Iorio B. Correction of metabolic acidosis in ESRD. Clinicaltrials.gov. NCT01640119. Accessed March 11, 2013
|
|
|
|
|
|
9）Melamed M. Placebo-controlled randomized clinical trial of alkali therapy in patients with chronic kidney disease. Clinicaltrials. gov. NCT01452412. Accessed March 11, 2013
|
|
|
|
|
|
10）Scialla JJ, Appel LJ, Astor BC, et al. African American Study of Kidney Disease and Hypertension Study Group. Net endogenous acid production is associated with a faster decline in GFR in African Americans. Kidney Int. 2012; 82: 106-12
|
|
|
|
|
|
11）Kanda E, Ai M, Kuriyama R, et al. Dietary acid intake and kidney disease progression in the elderly. Am J Nephrol. 2014; 39: 145-52
|
|
|
|
|
|
12）Goraya N, Simoni J, Jo C, et al. Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney Int. 2012; 81: 86-93
|
|
|
|
|
|
13）Goraya N, Simoni J, Jo CH, et al. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Clin J Am Soc Nephrol. 2013; 8: 371-81
|
|
|
|
|
|
14）Goraya N, Simoni J, Jo CH, et al. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate. Kidney Int. 2014; 86: 1031-8
|
|
|
|
|
|
15）Wesson DE, Simoni J. Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet. Kidney Int. 2010; 78: 1128-35
|
|
|
|
|
|
16）Wesson DE, Jo C-H, Simoni J. Animals with reduced GFR but no metabolic acidosis nevertheless have increased distal nephron acidification that is induced by acid retention and mediated through angiotensin II receptors. Kidney Int. 2012; 82: 1184-94
|
|
|
|
|